Literature DB >> 16322234

The Syk tyrosine kinase localizes to the centrosomes and negatively affects mitotic progression.

Déborah Zyss1, Philippe Montcourrier, Benjamin Vidal, Christelle Anguille, Fabrice Mérezègue, Alain Sahuquet, Paul H Mangeat, Peter J Coopman.   

Abstract

We showed previously that the spleen tyrosine kinase Syk is expressed by mammary epithelial cells and that it suppresses malignant growth of breast cancer cells. The exact molecular mechanism of its tumor-suppressive activity remains, however, to be identified. Here, we show that Syk colocalizes and copurifies with the centrosomal component gamma-tubulin and exhibits a catalytic activity within the centrosomes. Moreover, its centrosomal localization depends on its intact kinase activity. Centrosomal Syk expression is persistent in interphase but promptly drops during mitosis, obviously resulting from its ubiquitinylation and proteasomal degradation. Conversely, unrestrained exogenous expression of a fluorescently tagged Discosoma sp. red fluorescent protein (DsRed)-Syk chimera engenders abnormal cell division and cell death. Transient DsRed-Syk overexpression triggers an abrupt cell death lacking hallmarks of classic apoptosis but reminiscent of mitotic catastrophe. Surviving stable DsRed-Syk-transfected cells exhibit multipolar mitotic spindles and contain multiple abnormally sized nuclei and supernumerary centrosomes, revealing anomalous cell division. Taken together, these results show that Syk is a novel centrosomal kinase that negatively affects cell division. Its expression is strictly controlled in a spatiotemporal manner, and centrosomal Syk levels need to decline to allow customary progression of mitosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322234     DOI: 10.1158/0008-5472.CAN-05-1270

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates.

Authors:  Liang Xue; Wen-Horng Wang; Anton Iliuk; Lianghai Hu; Jacob A Galan; Shuai Yu; Michael Hans; Robert L Geahlen; W Andy Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

2.  The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability.

Authors:  Antonietta Rosella Farina; Antonella Tacconelli; Lucia Cappabianca; Gesilia Cea; Sonia Panella; Antonella Chioda; Alessandra Romanelli; Carlo Pedone; Alberto Gulino; Andrew Reay Mackay
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

3.  Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors.

Authors:  Brit Neuhaus; Sebastian Bühren; Barbara Böck; Frauke Alves; Wolfgang F Vogel; Friedemann Kiefer
Journal:  Cell Mol Life Sci       Date:  2011-04-17       Impact factor: 9.261

4.  Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis.

Authors:  So-Hyun Shin; Kwang Ho Lee; Baek-Hee Kim; Sun Lee; Hwan Seok Lee; Ja-June Jang; Gyeong Hoon Kang
Journal:  Lab Invest       Date:  2014-10-13       Impact factor: 5.662

5.  Reactivation of Syk gene by AZA suppresses metastasis but not proliferation of breast cancer cells.

Authors:  Tian-Song Xia; Jing-Ping Shi; Qiang Ding; Xiao-An Liu; Yi Zhao; Yue-Xian Liu; Jian-Guo Xia; Shui Wang; Yong-Bin Ding
Journal:  Med Oncol       Date:  2011-02-24       Impact factor: 3.064

6.  Insights into the allosteric regulation of Syk association with receptor ITAM, a multi-state equilibrium.

Authors:  Chao Feng; Carol Beth Post
Journal:  Phys Chem Chem Phys       Date:  2016-02-17       Impact factor: 3.676

7.  Delocalization of gamma-tubulin due to increased solubility in human breast cancer cell lines.

Authors:  Edward H Cho; Rebecca A Whipple; Michael A Matrone; Eric M Balzer; Stuart S Martin
Journal:  Cancer Biol Ther       Date:  2010-01-28       Impact factor: 4.742

8.  Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest.

Authors:  Olivier Bailet; Nina Fenouille; Patricia Abbe; Guillaume Robert; Stéphane Rocchi; Nadège Gonthier; Christophe Denoyelle; Michel Ticchioni; Jean-Paul Ortonne; Robert Ballotti; Marcel Deckert; Sophie Tartare-Deckert
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

9.  Modulation by Syk of Bcl-2, calcium and the calpain-calpastatin proteolytic system in human breast cancer cells.

Authors:  Bei Fei; Shuai Yu; Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2013-05-16

10.  The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells.

Authors:  Q Zhou; R L Geahlen
Journal:  Oncogene       Date:  2009-01-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.